- Home
- TNXP vs PAMT Comparison
TNXP vs PAMT Comparison
Compare TNXP & PAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- PAMT
- Stock Information
- Founded
- TNXP 2007
- PAMT 1980
- Country
- TNXP United States
- PAMT United States
- Employees
- TNXP N/A
- PAMT N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- PAMT Trucking Freight/Courier Services
- Sector
- TNXP Health Care
- PAMT Industrials
- Exchange
- TNXP Nasdaq
- PAMT Nasdaq
- Market Cap
- TNXP 272.0M
- PAMT 272.9M
- IPO Year
- TNXP N/A
- PAMT 1985
- Fundamental
- Price
- TNXP $35.48
- PAMT $14.22
- Analyst Decision
- TNXP Strong Buy
- PAMT Hold
- Analyst Count
- TNXP 2
- PAMT 1
- Target Price
- TNXP $585.00
- PAMT $12.50
- AVG Volume (30 Days)
- TNXP 729.5K
- PAMT 13.1K
- Earning Date
- TNXP 08-15-2025
- PAMT 07-23-2025
- Dividend Yield
- TNXP N/A
- PAMT N/A
- EPS Growth
- TNXP N/A
- PAMT N/A
- EPS
- TNXP N/A
- PAMT N/A
- Revenue
- TNXP $10,041,000.00
- PAMT $687,396,000.00
- Revenue This Year
- TNXP $11.66
- PAMT N/A
- Revenue Next Year
- TNXP $793.18
- PAMT $9.03
- P/E Ratio
- TNXP N/A
- PAMT N/A
- Revenue Growth
- TNXP N/A
- PAMT N/A
- 52 Week Low
- TNXP $6.76
- PAMT $11.01
- 52 Week High
- TNXP $130.00
- PAMT $23.70
- Technical
- Relative Strength Index (RSI)
- TNXP 52.96
- PAMT N/A
- Support Level
- TNXP $33.71
- PAMT N/A
- Resistance Level
- TNXP $38.13
- PAMT N/A
- Average True Range (ATR)
- TNXP 2.62
- PAMT 0.00
- MACD
- TNXP -0.44
- PAMT 0.00
- Stochastic Oscillator
- TNXP 61.01
- PAMT 0.00
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About PAMT PAMT CORP Common Stock
PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.